Debbie Rigby rounds up the latest in research news Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates In this large cohort study, the risk of atypical femur fracture increased with longer duration of bisphosphonate use (mainly alendronate) and rapidly decreased after bisphosphonate discontinuation. Asians had a higher risk than Whites. The absolute risk
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.